Valneva announces plans to accelerate pediatric development of its Lyme vaccine candidate
by Press Release from Outbreak News Today on (#5B5YV)
By NewsDesk @bactiman63 Specialty vaccine company, Valneva SE, announced yesterday its plans to accelerate pediatric development of its Lyme vaccine candidate, VLA15, in collaboration with Pfizer Inc., with the planned initiation of study VLA15-221 in the first quarter of 2021, subject to regulatory approval. VLA15-221 is planned as a randomized, observer-blind, placebo-controlled Phase 2 study. Currently, [...]
The post Valneva announces plans to accelerate pediatric development of its Lyme vaccine candidate appeared first on Outbreak News Today.